Biomedical subjects
Ravi Jhaveri
Publications and source records attributed to Ravi Jhaveri.
Results of a local modified Delphi consensus on use of plasma metagenomic next-generation sequencing.
Molecular tests without well-defined test performance characteristics are increasingly available for diagnosis of infectious diseases. These tests present a diagnostic stewardship challenge for institutions. We share the results of a local modified Delphi consensus undertaken to define appropriate scenarios for use of plasma metagenomic next-generation sequencing.
Direct cost savings associated with reduction in plasma metagenomic sequencing.
Following recognition that our hospital had higher use of plasma metagenomic next-generation sequencing than our peers, we implemented a process for approval by infectious diseases before test collection. This intervention is calculated to result in a direct cost savings of $79,505-$84,057/year, driven mainly by reduced laboratory costs.